Share-based Payment Arrangement, Expense of Vaxart, Inc. from 25 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vaxart, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 25 Jun 2011 to 30 Sep 2025.
  • Vaxart, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,018,000, a 18% decline year-over-year.
  • Vaxart, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $8,953,000, a 30% decline year-over-year.
  • Vaxart, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $11,501,000, a 19% decline from 2023.
  • Vaxart, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14,132,000, a 4% increase from 2022.
  • Vaxart, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13,587,000, a 53% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Vaxart, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,953,000 $2,018,000 -$457,000 -18% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $9,410,000 $2,121,000 -$434,000 -17% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $9,844,000 $2,459,000 -$1,657,000 -40% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $11,501,000 $2,355,000 -$1,360,000 -37% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $12,861,000 $2,475,000 -$1,368,000 -36% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $14,229,000 $2,555,000 -$1,372,000 -35% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $15,601,000 $4,116,000 +$1,469,000 +55% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $14,132,000 $3,715,000 +$322,000 +9.5% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $13,810,000 $3,843,000 +$200,000 +5.5% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $13,610,000 $3,927,000 +$506,000 +15% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $13,104,000 $2,647,000 -$483,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $13,587,000 $3,393,000 +$480,000 +16% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $13,107,000 $3,643,000 +$1,544,000 +74% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $11,563,000 $3,421,000 +$817,000 +31% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $10,746,000 $3,130,000 +$1,879,000 +150% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $8,867,000 $2,913,000 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $2,099,000 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $2,604,000 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $1,251,000 +$1,155,000 +1203% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $559,000 $96,000 -$68,000 -41% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $627,000 $137,000 -$15,000 -9.9% 01 Oct 2019 31 Dec 2019 10-K 19 Mar 2020 2019 FY
Q3 2019 $642,000 $146,000 -$37,000 -20% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $679,000 $180,000 +$62,000 +53% 01 Apr 2019 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $617,000 $164,000 +$78,000 +91% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q4 2018 $539,000 $152,000 +$49,000 +48% 01 Oct 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q3 2018 $490,000 $183,000 +$62,000 +51% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $428,000 $118,000 -$11,000 -8.5% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $439,000 $86,000 -$38,000 -31% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $477,000 $103,000 -$397,000 -79% 01 Oct 2017 31 Dec 2017 10-K 06 Feb 2019 2018 FY
Q3 2017 $874,000 $121,000 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $129,000 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2
Q1 2017 $124,000 -$376,000 -75% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $500,000 -$100,000 -17% 01 Oct 2016 31 Dec 2016 10-Q 06 Feb 2017 2017 Q2
Q1 2016 $500,000 -$100,000 -17% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q3
Q4 2015 $600,000 01 Oct 2015 31 Dec 2015 10-Q 06 Feb 2017 2017 Q2
Q1 2015 $600,000 +$100,000 +20% 01 Jan 2015 31 Mar 2015 10-Q 08 May 2015 2015 Q3
Q1 2014 $500,000 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q3
Q3 2012 $1,200,000 +$400,000 +50% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $700,000 +$100,000 +17% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q3 2011 $800,000 01 Jul 2011 24 Sep 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 $600,000 27 Mar 2011 25 Jun 2011 10-Q 09 Aug 2012 2012 Q2

Vaxart, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $11,501,000 -$2,631,000 -19% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $14,132,000 +$545,000 +4% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $13,587,000 +$4,720,000 +53% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $8,867,000 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2019 $627,000 +$88,000 +16% 01 Jan 2019 31 Dec 2019 10-K 19 Mar 2020 2019 FY
2018 $539,000 +$62,000 +13% 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
2017 $477,000 -$1,523,000 -76% 01 Jan 2017 31 Dec 2017 10-K 06 Feb 2019 2018 FY
2016 $2,000,000 01 Jul 2015 30 Jun 2016 10-K 01 Sep 2017 2017 FY
2013 $500,000 01 Jul 2012 30 Jun 2013 10-K 27 Sep 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.